These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33628839)

  • 1. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.
    Li Y; Wang L; Xu B; Zhao L; Li L; Xu K; Tang A; Zhou S; Song L; Zhang X; Zhan H
    J Diabetes Res; 2021; 2021():8891093. PubMed ID: 33628839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
    Guo MF; Dai YJ; Gao JR; Chen PJ
    J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and
    Han Y; Wei S; Liu C; Nie Y; Yuan S; Ma Y; Zhao Y; Zhang G
    Comb Chem High Throughput Screen; 2024; 27(14):2078-2089. PubMed ID: 37861047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis.
    Qian Y; Sun X; Wang X; Yang X; Fan M; Zhong J; Pei Z; Guo J
    J Diabetes Res; 2021; 2021():5477941. PubMed ID: 34621904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
    Fu S; Zhou Y; Hu C; Xu Z; Hou J
    BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on network pharmacological mechanism of "treating different diseases with same method" of Notoginseng Radix et Rhizoma in treating diabetic nephropathy, diabetic encephalopathy and diabetic cardiomyopathy].
    Xiang CP; Zhou R; Zhang JJ; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2424-2433. PubMed ID: 34047086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
    Dong Y; Zhao Q; Wang Y
    Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology and Molecular Docking Analysis Explores the Mechanisms of
    Ma H; Wang G; Guo X; Yao Y; Li C; Li X; Xin M; Xu X; Zhang S; Sun Z; Zhao H
    J Oncol; 2022; 2022():3156785. PubMed ID: 36072973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Pharmacology Approach to Uncover the Mechanism Governing the Effect of Simiao Powder on Knee Osteoarthritis.
    Huang Z; Shi X; Li X; Zhang L; Wu P; Mao J; Xing R; Zhang N; Wang P
    Biomed Res Int; 2020; 2020():6971503. PubMed ID: 33376732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
    Yu Y; Yang F; Liu H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
    Lin Y; Shen C; Wang F; Fang Z; Shen G
    J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.